Broncochem Cold & Flu Syrup Kids Recalled Due to Stability Testing Failures
Global Corporation is recalling Broncochem Cold & Flu Syrup Kids (120 mL bottles) nationwide due to stability testing failures in active pharmaceutical ingredients.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II voluntary recall due to stability testing failures with no reported illnesses or injuries. The hazard—potential degradation of active pharmaceutical ingredients affecting drug efficacy—is theoretical rather than documented harm.
Plain-English summary
Global Corporation is recalling Broncochem Cold & Flu Syrup Kids (120 mL bottles) due to stability testing failures in the finished product. The company identified that one or two of the active pharmaceutical ingredients—specifically Phenylephrine HCL and/or Chlorpheniramine Maleate—failed stability testing.
The affected product includes lot numbers #223002 (expiration date 10/2025) and #223063 (expiration date 02/2026). Approximately 9,831 bottles have been distributed nationwide. Stability failures mean these products may not maintain the intended potency or quality of the active ingredients throughout their shelf life.
No illnesses or injuries related to this product have been reported. This is a Class II recall initiated by the manufacturer.
The recalled product
- Product
- Broncochem Cold & Flu Syrup Kids (acetaminophen, guaifenesin, phenylephrine HCl), packaged in 120 mL bottles, Made in Dominican Republic Exclusively for Global Corporation Inc, Boca Raton, FL 33187 USA, NDC 65131-098-44
- Manufacturer
- Global Corporation
- Category
- Drug — OTC Cough & Cold Syrup
- Hazard
- stability-failure
- drug-degradation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 223002
- Exp. Date 10/2025
- 223063
- Exp. Date 02/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27